Ann Boriack-Sjodin

Senior Vice President, Molecular Discovery @ Accent Therapeutics arrow icon

Known information

  • Holds a PhD
  • Has a background in molecular discovery

About Accent Therapeutics

Accent Therapeutics, based in Lexington, MA, develops small molecule therapeutics targeting RNA-modifying proteins for cancer treatment. The company has a partnership with AstraZeneca and has raised $75 million in Series C financing.

report flag Report inaccurate information

People similar to Ann Boriack-Sjodin

Stephen Blakemore

Vice President, Biological & Translational Sciences @ Accent Therapeutics

Stuart J. Ince

Vice President, Program Leadership @ Accent Therapeutics

Steve Mennen

Vice President, Pre-Clinical Development @ Accent Therapeutics

Unlock exclusive insights

Sign up to reveal more information.

loader Sign up for free